Get the Stockscreener App
8.42
0.24%
-0.02
After Hours:
8.42
Kamada Ltd stock is traded at $8.42, with a volume of 37,066.
It is down -0.24% in the last 24 hours and down -3.22% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$8.44
Open:
$8.41
24h Volume:
37,066
Relative Volume:
0.50
Market Cap:
$485.72M
Revenue:
$180.46M
Net Income/Loss:
$20.20M
P/E Ratio:
24.28
EPS:
0.3468
Net Cash Flow:
$16.59M
1W Performance:
+2.06%
1M Performance:
-3.22%
6M Performance:
+23.46%
1Y Performance:
+34.08%
1-Day Range:
$8.41
$8.565
1-Week Range:
$8.31
$8.60
52-Week Range:
$6.24
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.42 | 489.75M | 180.46M | 20.20M | 16.59M | 0.3468 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Kamada Announces Successful GMP Manufacturing Audit by Israel's Ministry of Health - Yahoo
KMDA SEC FilingsKamada Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Investment Report: Is Kamada Ltd stock overvalued or fairly priced2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options - Benzinga
Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options - Benzinga
David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options - Benzinga
Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition - Benzinga
Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired - Benzinga
Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired - Benzinga
Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K - Benzinga
Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition - Benzinga
Assaf Itshayek Sees Potential Growth And Acquires Kamada Stock Options Worth $41K - Benzinga
Hanni Neheman Backs Up Beliefs With A Notable $118K Acquisition In Kamada Stock Options - Benzinga
Karnit Goldwasser At Kamada Secures Company Stock Options: $115K Acquired - Benzinga
Amir London Takes A Bullish Stance, Acquiring $1.56M Worth Of Kamada Stock Options - Benzinga
Boris Gorelik Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $-9K - Benzinga
Kamada (KMDA) VP reports trustee-held stock option grant and return - Stock Titan
Kamada (KMDA) VP awarded options as prior grants are price-adjusted - Stock Titan
Kamada (KMDA) CEO reports trustee-held option grants and cancellations - Stock Titan
Kamada (KMDA) director reports trustee-held option grants and cancellations - Stock Titan
[Form 4] KAMADA LTD Insider Trading Activity - Stock Titan
Director at Kamada (NASDAQ: KMDA) reports trustee-held option awards and price adjustments - Stock Titan
Option awards adjusted for Kamada (KMDA) director after cash dividend - Stock Titan
Kamada (NASDAQ: KMDA) director logs trustee-held option adjustments - Stock Titan
Kamada (KMDA) VP Livneh granted and adjusts trustee-held stock options - Stock Titan
Kamada (KMDA) adjusts CFO stock options following cash dividend move - Stock Titan
Kamada (NASDAQ: KMDA) director reports trustee-held option adjustments - Stock Titan
Kamada (KMDA) VP awarded 15,000 employee stock options in Form 4 - Stock Titan
Kamada (KMDA) director adjusts option awards after cash dividend change - Stock Titan
Kamada (KMDA) VP logs trustee‑held option grants and disposals - Stock Titan
Kamada (KMDA) VP grants and surrenders 112,500 stock options under 2011 plan - Stock Titan
Kamada (KMDA) VP Brenner reports employee option adjustments after dividend - Stock Titan
Stock options for Kamada (KMDA) director adjusted after dividend - Stock Titan
KMDA PE Ratio & Valuation, Is KMDA Overvalued - intellectia.ai
Kamada Ltd Earnings Call Signals Confident Growth Path - The Globe and Mail
Kamada obtains Israeli tax ruling for $14.4M dividend payment By Investing.com - Investing.com South Africa
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend - GuruFocus
Kamada Details Israeli Withholding Terms for April 7 Cash Dividend - TipRanks
Kamada (NASDAQ: KMDA) outlines Israeli tax relief on $0.25 dividend - Stock Titan
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders - ChartMill
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade) (NASDAQ:KMDA) - Seeking Alpha
Kamada’s San Antonio plasma center wins FDA approval By Investing.com - Investing.com South Africa
Aug PreEarnings: Can Kamada Ltd continue delivering strong returns2026 Short Interest & Community Trade Idea Sharing - baoquankhu1.vn
Kamada (KMDA) Gains FDA Approval for San Antonio Plasma Center - gurufocus.com
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas - Bitget
FDA Approves Kamada's (KMDA) Plasma Collection Facility in Texas - GuruFocus
Kamada Wins FDA Nod for High-Capacity San Antonio Plasma Center - TipRanks
Kamada’s San Antonio plasma center wins FDA approval - Investing.com
FDA clears Kamada (NASDAQ: KMDA) San Antonio plasma collection center - Stock Titan
Earnings call transcript: Kamada Ltd. misses Q4 2025 forecasts, stock dips - Investing.com Australia
Earnings call transcript: Kamada Ltd. misses Q4 2025 forecasts, stock dips By Investing.com - Investing.com South Africa
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):